Source: U.S. News & World Report
The official website of the Kataeb Party leader
Security & Justice
Israeli Army Issues Urgent Warning to Southern Lebanon Residents
Israeli army spokesperson Avichay Adraee called on southern Lebanon residents to stay away from the border areas, citing severe risks from active combat zones.
Friday, November 8, 2024
Lebanon State Media Says Israel Blows Up Houses in Three Border Villages
Lebanon state media said the Israeli army on Friday detonated explosives planted inside houses in three border villages that have been battered by the Israel-Hezbollah war.
Friday, November 8, 2024
Opinion
A Message for America: A Free Lebanon Is the Only Path to Truly Stopping Hezbollah
On Thursday, White House officials returned from a visit to Israel, in a last-ditch effort to broker a ceasefire between Israel and Hezbollah, which now looks unlikely to happen before this week’s presidential election. After the election, for any diplomatic path to be viable, the world first needs to see Lebanon establish a new anti-Hezbollah government that demands Hezbollah surrender its arms to the Lebanese Armed Forces.
Tuesday, November 5, 2024
Amid Costly War with Israel, Hezbollah Faces Fire from Its Own Supporters
With Hezbollah and Israel locked in another punishing war, disappointment and anger echo increasingly across Lebanon’s Shiite community, which has borne the brunt of thousands of Israeli airstrikes in south and east Lebanon and the southern suburbs of Beirut.
Monday, November 4, 2024
Sports
Real Madrid, Manchester City Both Humiliated in Champions League, Liverpool Enjoy Alonso’s Return
European heavyweights Real Madrid and Manchester City both suffered big defeats in the Champions League on Tuesday.
Wednesday, November 6, 2024
Djokovic Pulls Out of ATP Finals
Defending champion Novak Djokovic has pulled out of the ATP Finals because of an "ongoing injury".
Tuesday, November 5, 2024
Thursday 3 November 2022 18:47:09
Pfizer Launches Trial of Flu, COVID-19 Combination Vaccine
Pfizer on Thursday announced that the first participant in a trial to examine an influenza and COVID-19 combination vaccine has been dosed.
The early-stage trial will examine the shot’s safety, tolerability and ability to provoke an immune response, according to Pfizer and its partner BioNTech. The shot includes Pfizer’s updated COVID-19 shot that is designed to take on the omicron variant.
Annaliesa Anderson of Pfizer’s vaccine research and development said that such a shot “could simplify immunization practices against these two respiratory pathogens, potentially leading to better vaccine uptake for both diseases.”
“Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world causing thousands of deaths and hospitalizations every year,” Anderson said in a statement.
The study will include 180 participants ranging from 18 to 64 years old.
“By combining both indications in one vaccine approach, we aim to provide individuals with an efficient way to receive immunization against two severe respiratory diseases with evolving viruses that require vaccine adaptation,” BioNTech CEO Ugur Sahin said in a statement.
The news comes as flu activity in the U.S. continues to increase. The first pediatric death from the flu was confirmed by the Centers for Disease Control and Prevention last week.
The CDC estimates that at least 6,900 people have been hospitalized with the flu so far this season, which is a level that hasn’t been recorded this early in the season going back over a decade.
Experts are concerned that low levels of immunity as well as the relaxation of COVID-19 mitigation measures could fuel a severe flu season as colder weather pushes more people indoors.